Company focused on developing and commercializing cannabis-based therapies and products.
India Globalization Capital, Inc. specializes in the acquisition and resale of physical infrastructure commodities, operating across two distinct segments: Infrastructure and Life Sciences. Within its Infrastructure segment, the company leases heavy construction equipment such as motor graders and rollers, and executes contracts for highway construction projects. In the Life Sciences sector, India Globalization Capital focuses on developing cannabinoid-based products and therapies. These include hemp-based tinctures marketed under the Hyalolex brand for anxiety relief and Alzheimer's management, CBD-based tinctures, capsules, and topical creams under the Holief brand for pain management, and a range of CBD-infused beauty products under the Herbo brand. Additionally, the company engages in wholesale distribution of hemp extracts under the Holi Hemp brand, production of lotions, creams, and oils, and offers white labeling services. It also processes crude oil into hemp extracts.
Founded in 2005 and headquartered in Potomac, Maryland, India Globalization Capital, Inc. operates in multiple regions including the United States, India, Colombia, and Hong Kong. The company's strategic focus on both infrastructure and life sciences underscores its diversified business approach and global footprint. By integrating operations across different markets, India Globalization Capital aims to leverage emerging opportunities and enhance its market position in the evolving sectors of construction equipment leasing and cannabinoid-based healthcare products.
With a commitment to innovation and expansion, India Globalization Capital continues to explore new avenues for growth while maintaining a robust presence in its core markets. The company's dual-sector strategy reflects its adaptability and resilience in navigating competitive landscapes and capitalizing on emerging trends in infrastructure and life sciences industries worldwide.